| Followers | 144 |
| Posts | 27997 |
| Boards Moderated | 4 |
| Alias Born | 02/07/2004 |
Friday, April 17, 2020 6:42:49 AM
BLRX soaked quite a lot of $$$
from my bank account. I left some
shares just for academic interest.
KTOV was one on my largest failures,
although i am in the deep red i still
keep it, for offsetting some gains in
others some time.
PARS was my largest loss by far, a
few years ago
TEVA was my largest gain ever.
BVXV has imo the largest potential if
of course they achieve FDA approval.
That said, there have been great Israeli
bio company success stories, and some
loud shattering collapses as well.
Take into consideration that Israel is #1
in foreign companies listed in the US.
Good Luck
from my bank account. I left some
shares just for academic interest.
KTOV was one on my largest failures,
although i am in the deep red i still
keep it, for offsetting some gains in
others some time.
PARS was my largest loss by far, a
few years ago
TEVA was my largest gain ever.
BVXV has imo the largest potential if
of course they achieve FDA approval.
That said, there have been great Israeli
bio company success stories, and some
loud shattering collapses as well.
Take into consideration that Israel is #1
in foreign companies listed in the US.
Good Luck
Recent SLGL News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/24/2026 09:16:03 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/24/2026 09:14:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/24/2026 04:15:06 AM
- Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering • GlobeNewswire Inc. • 03/24/2026 01:38:22 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/19/2026 09:03:09 PM
- Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025 • GlobeNewswire Inc. • 03/19/2026 12:53:28 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/19/2026 12:51:43 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 07:12:53 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:26:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:24:12 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:20:46 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:18:21 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:15:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/12/2026 11:11:02 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2026 11:21:09 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/24/2026 12:41:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/15/2026 11:54:30 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/17/2025 01:47:45 PM
- Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease • GlobeNewswire Inc. • 12/17/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/20/2025 01:44:10 PM
- Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 11/20/2025 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/14/2025 11:00:31 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/25/2025 06:12:52 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/04/2025 11:00:10 AM
- Sol-Gel Announces Health Canada Approval of EPSOLAY® • GlobeNewswire Inc. • 09/04/2025 11:00:00 AM
